NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Asclepii

Asclepii

Private
Cleveland, OhioHealthcare & Life Scienceshttps://asclepii.com/

Last Round

Grant

Apr 8, 2025

Total Funding Raised

$2.52M

Company Overview

Asclepii is a biotechnology company that develops regenerative medicine and advanced wound care solutions, including its flagship nanosilver hydrogel product, Poseidon.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

advanced wound careregenerative medicinenanosilver hydrogelextracellular matrixdiabetic foot ulcerswound dressingbiotech startuptissue regenerationmedical devicewound healingbiomaterialsmedtechchronic wound managementFDA-cleared

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Asclepii Comparables

Compare Asclepii with similar companies based on industry and business-model similarity.

Asclepii comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Organogenesis Holdings Inc.
75%
ConvaTec Group PLC
74%
ParaNano Wound Care
74%

Asclepii Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 8, 2025
SeedMar 21, 2025
GrantApr 26, 2024
AcceleratorApr 17, 2024
GrantMar 8, 2024

Key People

Founding team and executive leadership

Franco Kraiselburd

Founder & CEO

Founding Team

Asclepii Investors

Notable investors and investment history

Asclepii investors
InvestorRounds
VenturanceSeed
Zentynel Frontier InvestmentsSeed
JumpStartAccelerator
Capital FactorySeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2026

    Monthly visitors grew 42% MoM.

  • May 14, 2024

    Grew 100% QoQ from 4 to 8 employees.

Asclepii Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Asclepii Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Asclepii's valuation, stock price, and market status.

Firmographic Details

HeadquartersCleveland, Ohio
Employee Range13
Year Founded2022
Last FundingApr 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.